Real-time enrollment status for this solid tumours clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 8:02 PM UTC
| NCT Number | NCT07224425 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumours |
| Phase | PHASE1 |
| Target Enrollment | 69 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | July 22, 2026 (Jul 22, 2026) |
As of August 28, 2026: Clinical trial NCT07224425 is currently recruiting participants. This phase1 study for solid tumours is actively seeking new participants at 4 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07224425 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07224425 was last updated Jul 22, 2026 (July 22, 2026). HelloStudys verifies this status automatically.